NCT00245505View on ClinicalTrials.gov

"The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's Disease"

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Crohn's Disease
Interventions
DRUG

Mesalazine (Mesalamine)

Pentasa (mesalazine) sachets 2 g morning + 2 g evening during 12 weeks treatment

Trial Locations (1)

SE-205 02

Department of Medicine, Malmö University Hospital, Malmo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY